NASDAQ: CRBP
Corbus Pharmaceuticals Holdings Inc Stock Ownership - Who owns Corbus Pharmaceuticals Holdings?

Insider buying vs selling

Have Corbus Pharmaceuticals Holdings Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Anne AltmeyerDirector2025-05-301,392$7.25
$10.10kSell
John Kenneth JenkinsDirector2025-05-302,783$7.35
$20.47kSell
Dominic SmethurstChief Medical Officer2025-03-066,393$6.78
$43.33kSell
Yuval CohenChief Executive Officer2025-02-147,134$8.76
$62.47kSell
Sean F. MoranChief Financial Officer2025-02-142,792$8.76
$24.45kSell

1 of 1

CRBP insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CRBP insiders and whales buy or sell their stock.

CRBP Shareholders

What type of owners hold Corbus Pharmaceuticals Holdings Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Sumner Burstein29.33%3,594,571$69.45MInsider
Cormorant Asset Management LP22.99%2,817,368$54.43MInsider
Knoll Capital Management LP22.44%2,750,000$53.13MInsider
Cormorant Asset Management LP19.38%2,375,000$45.89MInstitution
Mark Tepper17.22%2,110,400$40.77MInsider
Orbimed Advisors LLC9.57%1,172,287$22.65MInstitution
Octagon Capital Advisors LP9.10%1,115,000$21.54MInstitution
David P. Hochman6.68%818,700$15.82MInsider
Vanguard Group Inc4.89%599,495$11.58MInstitution
Prosight Management LP4.73%579,893$11.20MInstitution

1 of 3

CRBP vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CRBP41.55%58.45%Net Selling
ENTA56.45%43.55%Net SellingNet Selling
CDXS48.25%51.75%Net BuyingNet Buying
SGMT34.93%65.07%Net SellingNet Selling
RNAC13.59%86.41%Net Buying

Corbus Pharmaceuticals Holdings Stock Ownership FAQ

Who owns Corbus Pharmaceuticals Holdings?

Corbus Pharmaceuticals Holdings (NASDAQ: CRBP) is owned by 73.94% institutional shareholders, 104.04% Corbus Pharmaceuticals Holdings insiders, and 0.00% retail investors. Sumner Burstein is the largest individual Corbus Pharmaceuticals Holdings shareholder, owning 3.59M shares representing 29.33% of the company. Sumner Burstein's Corbus Pharmaceuticals Holdings shares are currently valued at $69.45M.

If you're new to stock investing, here's how to buy Corbus Pharmaceuticals Holdings stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.